Pacer Advisors’s Solid Biosciences SLDB Stock Holding History

Pacer Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12K	Buy	+1,199	New	+$9.09K	﹤0.01%	2336

Other funds holding SLDB

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pacer Advisors's SLDB Position: Q2 2026 in Review

Pacer Advisors opened a new position in Solid Biosciences (SLDB) in Q2 2026: 1,199 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #2336 among its holdings.

156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

Pacer Advisors held 1,199 shares of Solid Biosciences worth $12K as of Q2 2026.
Solid Biosciences was a new Pacer Advisors position in Q2 2026.
Solid Biosciences made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2336 holding.
156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.